Solution Providers
from companies, universities, government labs, trade organizations and research
institutes around the world have come to rely on NineSigma’s innovation requests
to provide new sales channels and opportunities to advance their innovations. Solution
Providers speak out about what it means to be a part of the NineSigma Solution Provider
network. Interested
innovators may register online at
MyNineSigma to receive innovation requests from Global 1000 companies. If
you’d like to get in touch with our open innovation providers,
contact us about developing a Request for Proposal.
What our Open Innovation Providers are saying about the NineSigma process...
View our
Solution Provider Spotlight
for more in-depth commentary about the NineSigma process
"NineSigma provides us a great opportunity to present our innovations to Global
1000 companies and work with them to solve their technology challenges. The Request
process provides a unique opportunity to engage companies based on their specific
R&D directions. These are timely connections that are very difficult to form
otherwise. We have come to rely on NineSigma as a valuable channel for new opportunities
that we otherwise would not have known about."
Jon Dettling, North American Director for Ecointesys, a Swiss-based environmental
life-cycle assessment provider
"We like NineSigma’s process, which is much fairer to both parties than programs
used by other organizations. By submitting only non-confidential information, we
can attract the interest of the prospective client, but neither party makes any
significant commitment (e.g. intellectual property ownership) at the early stages.
This leaves everyone free to focus initially on finding the best technical solution."
Amlan Gupta, Founder and President of CG2 NanoCoatings, Canada
"The obvious benefit of working with NineSigma is that we got a substantial contract.
($1.8M USD, initial stage contract with a Fortune 50 NineSigma client). We also
received a contract to do some development work to drive the technology forward…we
anticipate that we will work with this client through two additional stages to get
to manufacturing."
Alexander Gosling, Director, Invetech Pty Ltd., Australia
"The client was looking for a development platform and product candidates that our
company was already working on involving ergonomic bioactivity, which is a core
R&D capability at Phytomedics. It was something we were already working on that
fit in very nicely with what they were looking for. We absolutely recommend NineSigma
to other innovators, particularly because of the nice synergy with sophisticated
R&D organizations such as ours."
Ira Pastor, VP Business Development, Phytomedics Inc., New Jersey, after signing
a $270K development contract with a Fortune 100 NineSigma client
"We currently have technologies ready for evaluation and demonstration and were
pleased to have the opportunity to respond to the [NineSigma] request. Our technology
was chosen by the company and we signed a contract in excess of $100K USD. Without
NineSigma, we would not have known that this particular company was looking for
something that we already had."
Dr. Birgitta Raaholt, The Swedish Institute for Food and Biotechnology, Sweden
"We have submitted several project proposals in response to NineSigma RFPs over
the past two years. We have successfully connected with two global consumer goods
companies for work on their projects. We have known these companies well through
other business development efforts, but NineSigma gave us new entry points into
these companies. NineSigma's process makes it easy for our organization to quickly
scan a variety of technical needs in our area and make a decision on which opportunities
to pursue."
Ronald Korstanje, Vice President of Business Development, TNO Life Science Inc.,
The Netherlands
"Our relationship with NineSigma is an ideal match of their publicizing market needs
with our knowledge of available technology."
Allan Jarry, Executive Director, NEOS, Chile
View
Case Studies
to learn what Clients are saying about the NineSigma process.